Please login to the form below

Not currently logged in
Email:
Password:

open letter

This page shows the latest open letter news and features for those working in and with pharma, biotech and healthcare.

Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’

Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’

CEO writes open letter to prime minister. Fresh from the news that the NHS in England still isn’t minded to fund treatment with its cystic fibrosis therapy Orkambi, Vertex Pharma ... The letter to Theresa May asks for her “urgent intervention” in

Latest news

  • Moving times Moving times

    At the end of August, a group of LGBT EMA employees wrote an open letter to Guido Rasi (executive director of the EMA), Donald Tusk, Jean-Claude Juncker and Antonio Tajani ... affected by the EMA relocation.’ Naturally the letter does not cite any

  • EU and UK pharma leaders appeal directly to Brexit negotiators EU and UK pharma leaders appeal directly to Brexit negotiators

    Eight associations from the UK and Europe have written an open letter to the negotiators to plead for an early partnership agreement on medicines, saying that drugs could be "held either ... An implementation period that adequately reflects the time

  • UK pharma strikes optimistic note as Brexit process begins UK pharma strikes optimistic note as Brexit process begins

    All eyes are now on the preliminary response to the letter triggering Brexit - which European Council president Donald Tusk has said will be ready on Friday – and which expressed Prime Minister ... Industry eyes no doubt latched onto May emphasising

  • Biotech leaders slam Trump over immigration order Biotech leaders slam Trump over immigration order

    Former Teva CEO Jeremy Levin heads open letter expressing “deep concern and opposition”. ... In an open letter published in Nature Biotech yesterday, the biotech leaders express "deep concern and opposition" to the executive order that barred

  • UK biotech beats fundraising records in 2015, says BIA UK biotech beats fundraising records in 2015, says BIA

    Last month, more than 90 top executives in the UK's biopharma industry added their names to an open letter warning of "complexity and uncertainty" if the UK votes to leave

More from news
Approximately 0 fully matching, plus 24 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics